FDA Approval of IDE to Initiate Multi-Center Investigator-Initiated Study of Alpha DaRT® in Immunocompromised Patients with Recurrent cSCC

Main
News

News

Admin
Sep 20 2024

[Press Release]

FDA Approval of IDE to Initiate Multi-Center Investigator-Initiated Study of Alpha DaRT® in Immunocompromised Patients with Recurrent cSCC

https://www.alphatau.com/single-post/fda-approval-of-ide-to-initiate-multi-center-investigator-initiated-study-of-alpha-dart-in-immunoco

Previous: StoreDot welcomes top auto industry analyst Rod Lache to its advisory board, further expanding globally Sep 18 2024

Next: Ultra-Red has expanded its operations in Japan through a new partnership with GSX Sep 24 2024

List